nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—Methotrexate—hematologic cancer	0.406	1	CbGbCtD
Trimetrexate—DHFR—hematopoietic system—hematologic cancer	0.00623	0.218	CbGeAlD
Trimetrexate—DHFR—gonad—hematologic cancer	0.00473	0.166	CbGeAlD
Trimetrexate—DHFR—blood—hematologic cancer	0.00412	0.144	CbGeAlD
Trimetrexate—DHFR—bone marrow—hematologic cancer	0.00399	0.14	CbGeAlD
Trimetrexate—DHFR—lung—hematologic cancer	0.00362	0.127	CbGeAlD
Trimetrexate—DHFR—testis—hematologic cancer	0.00341	0.119	CbGeAlD
Trimetrexate—DHFR—lymph node—hematologic cancer	0.00247	0.0866	CbGeAlD
Trimetrexate—DHFR—Cell Cycle, Mitotic—SMC3—hematologic cancer	0.000536	0.00326	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—RB1—hematologic cancer	0.000533	0.00324	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—RAD21—hematologic cancer	0.000515	0.00314	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MYBL2—hematologic cancer	0.000514	0.00313	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—IL1B—hematologic cancer	0.000508	0.00309	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—IL2—hematologic cancer	0.000506	0.00308	CbGpPWpGaD
Trimetrexate—DHFR—Disease—LYZ—hematologic cancer	0.000503	0.00306	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—SMC3—hematologic cancer	0.000479	0.00292	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—CDKN1B—hematologic cancer	0.000477	0.00291	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MYBL2—hematologic cancer	0.000459	0.00279	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—POT1—hematologic cancer	0.000459	0.00279	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDK2—hematologic cancer	0.000456	0.00278	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—MDM2—hematologic cancer	0.000454	0.00277	CbGpPWpGaD
Trimetrexate—DHFR—G1/S Transition—RB1—hematologic cancer	0.000445	0.00271	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—CDKN1A—hematologic cancer	0.000441	0.00268	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDK4—hematologic cancer	0.000431	0.00262	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—ATR—hematologic cancer	0.000427	0.0026	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—STAG2—hematologic cancer	0.000426	0.00259	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—EP300—hematologic cancer	0.000419	0.00255	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—CDKN1B—hematologic cancer	0.000415	0.00252	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PPEF1—hematologic cancer	0.00041	0.0025	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—CCND1—hematologic cancer	0.000396	0.00241	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—H3F3B—hematologic cancer	0.000389	0.00237	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—FOXM1—hematologic cancer	0.000389	0.00237	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—CDKN1A—hematologic cancer	0.000383	0.00233	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—STAG2—hematologic cancer	0.000381	0.00232	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GMPS—hematologic cancer	0.000376	0.00229	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PHYH—hematologic cancer	0.000376	0.00229	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—FTCD—hematologic cancer	0.000376	0.00229	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—RB1—hematologic cancer	0.000375	0.00228	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—TNF—hematologic cancer	0.000369	0.00224	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CCND3—hematologic cancer	0.000368	0.00224	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—MYC—hematologic cancer	0.000365	0.00222	CbGpPWpGaD
Trimetrexate—DHFR—Disease—B3GAT1—hematologic cancer	0.000359	0.00218	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CHMP5—hematologic cancer	0.000359	0.00218	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—NUP98—hematologic cancer	0.000351	0.00213	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—H3F3B—hematologic cancer	0.000348	0.00212	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—FOXM1—hematologic cancer	0.000348	0.00212	CbGpPWpGaD
Trimetrexate—DHFR—G1/S Transition—CDKN1B—hematologic cancer	0.000346	0.00211	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SMPD3—hematologic cancer	0.000344	0.00209	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—NUP214—hematologic cancer	0.000338	0.00206	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—NPM1—hematologic cancer	0.000335	0.00204	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDKN2A—hematologic cancer	0.00033	0.00201	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CCND3—hematologic cancer	0.000329	0.002	CbGpPWpGaD
Trimetrexate—Vomiting—Nilotinib—hematologic cancer	0.000326	0.000814	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—TP53—hematologic cancer	0.000325	0.00198	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HDAC11—hematologic cancer	0.000324	0.00197	CbGpPWpGaD
Trimetrexate—Vomiting—Imatinib—hematologic cancer	0.000324	0.000809	CcSEcCtD
Trimetrexate—Pruritus—Melphalan—hematologic cancer	0.000323	0.000807	CcSEcCtD
Trimetrexate—Rash—Nilotinib—hematologic cancer	0.000323	0.000807	CcSEcCtD
Trimetrexate—Body temperature increased—Bortezomib—hematologic cancer	0.000323	0.000807	CcSEcCtD
Trimetrexate—Dermatitis—Nilotinib—hematologic cancer	0.000323	0.000806	CcSEcCtD
Trimetrexate—Neutropenia—Prednisone—hematologic cancer	0.000323	0.000806	CcSEcCtD
Trimetrexate—Thrombocytopenia—Irinotecan—hematologic cancer	0.000322	0.000805	CcSEcCtD
Trimetrexate—Thrombocytopenia—Mitoxantrone—hematologic cancer	0.000322	0.000805	CcSEcCtD
Trimetrexate—Rash—Imatinib—hematologic cancer	0.000321	0.000802	CcSEcCtD
Trimetrexate—Dermatitis—Imatinib—hematologic cancer	0.000321	0.000801	CcSEcCtD
Trimetrexate—Body temperature increased—Bleomycin—hematologic cancer	0.000321	0.0008	CcSEcCtD
Trimetrexate—DHFR—G1/S Transition—CDKN1A—hematologic cancer	0.00032	0.00195	CbGpPWpGaD
Trimetrexate—Asthenia—Lenalidomide—hematologic cancer	0.000319	0.000796	CcSEcCtD
Trimetrexate—Vomiting—Cladribine—hematologic cancer	0.000318	0.000795	CcSEcCtD
Trimetrexate—Fatigue—Thalidomide—hematologic cancer	0.000318	0.000793	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—MYC—hematologic cancer	0.000318	0.00193	CbGpPWpGaD
Trimetrexate—Convulsion—Cisplatin—hematologic cancer	0.000317	0.000792	CcSEcCtD
Trimetrexate—Rash—Cladribine—hematologic cancer	0.000316	0.000788	CcSEcCtD
Trimetrexate—Body temperature increased—Vinorelbine—hematologic cancer	0.000316	0.000788	CcSEcCtD
Trimetrexate—Dermatitis—Cladribine—hematologic cancer	0.000316	0.000788	CcSEcCtD
Trimetrexate—Pruritus—Lenalidomide—hematologic cancer	0.000314	0.000785	CcSEcCtD
Trimetrexate—Asthenia—Hydroxyurea—hematologic cancer	0.000314	0.000784	CcSEcCtD
Trimetrexate—Feeling abnormal—Thiotepa—hematologic cancer	0.000314	0.000784	CcSEcCtD
Trimetrexate—Thrombocytopenia—Gemcitabine—hematologic cancer	0.000314	0.000784	CcSEcCtD
Trimetrexate—Hyponatraemia—Epirubicin—hematologic cancer	0.000314	0.000783	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—NUP98—hematologic cancer	0.000313	0.00191	CbGpPWpGaD
Trimetrexate—Nausea—Chlorambucil—hematologic cancer	0.000311	0.000777	CcSEcCtD
Trimetrexate—DHFR—Disease—BCR—hematologic cancer	0.000311	0.00189	CbGpPWpGaD
Trimetrexate—DHFR—Disease—LIG4—hematologic cancer	0.000311	0.00189	CbGpPWpGaD
Trimetrexate—Anaemia—Etoposide—hematologic cancer	0.00031	0.000774	CcSEcCtD
Trimetrexate—Vomiting—Vinblastine—hematologic cancer	0.000305	0.000762	CcSEcCtD
Trimetrexate—Nausea—Nilotinib—hematologic cancer	0.000305	0.00076	CcSEcCtD
Trimetrexate—Feeling abnormal—Thalidomide—hematologic cancer	0.000304	0.000758	CcSEcCtD
Trimetrexate—Nausea—Imatinib—hematologic cancer	0.000303	0.000756	CcSEcCtD
Trimetrexate—Fatigue—Alitretinoin—hematologic cancer	0.000302	0.000755	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—NUP214—hematologic cancer	0.000302	0.00184	CbGpPWpGaD
Trimetrexate—Body temperature increased—Thiotepa—hematologic cancer	0.000301	0.000752	CcSEcCtD
Trimetrexate—DHFR—Metabolism—B3GAT1—hematologic cancer	0.0003	0.00183	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ASNS—hematologic cancer	0.0003	0.00183	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—DCK—hematologic cancer	0.0003	0.00183	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PSIP1—hematologic cancer	0.000299	0.00182	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PC—hematologic cancer	0.000299	0.00182	CbGpPWpGaD
Trimetrexate—Fatigue—Ifosfamide—hematologic cancer	0.000299	0.000746	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—SMC1A—hematologic cancer	0.000298	0.00181	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—IL6—hematologic cancer	0.000298	0.00181	CbGpPWpGaD
Trimetrexate—Nausea—Cladribine—hematologic cancer	0.000298	0.000743	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—TOP2A—hematologic cancer	0.000295	0.0018	CbGpPWpGaD
Trimetrexate—Asthenia—Bortezomib—hematologic cancer	0.000293	0.000732	CcSEcCtD
Trimetrexate—Thrombocytopenia—Cisplatin—hematologic cancer	0.000293	0.000731	CcSEcCtD
Trimetrexate—Blood creatinine increased—Epirubicin—hematologic cancer	0.000293	0.00073	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—H3F3A—hematologic cancer	0.000292	0.00178	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDKN1B—hematologic cancer	0.000292	0.00178	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Carmustine—hematologic cancer	0.000292	0.000728	CcSEcCtD
Trimetrexate—Body temperature increased—Thalidomide—hematologic cancer	0.000291	0.000728	CcSEcCtD
Trimetrexate—Fatigue—Vincristine—hematologic cancer	0.000291	0.000727	CcSEcCtD
Trimetrexate—Asthenia—Bleomycin—hematologic cancer	0.000291	0.000727	CcSEcCtD
Trimetrexate—Convulsion—Etoposide—hematologic cancer	0.000291	0.000726	CcSEcCtD
Trimetrexate—Vomiting—Melphalan—hematologic cancer	0.000291	0.000725	CcSEcCtD
Trimetrexate—Hyponatraemia—Doxorubicin—hematologic cancer	0.00029	0.000724	CcSEcCtD
Trimetrexate—Pruritus—Bortezomib—hematologic cancer	0.000289	0.000722	CcSEcCtD
Trimetrexate—Feeling abnormal—Alitretinoin—hematologic cancer	0.000289	0.000722	CcSEcCtD
Trimetrexate—DHFR—Disease—HDAC10—hematologic cancer	0.000289	0.00176	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SLC35B2—hematologic cancer	0.000289	0.00176	CbGpPWpGaD
Trimetrexate—Rash—Melphalan—hematologic cancer	0.000288	0.000719	CcSEcCtD
Trimetrexate—Dermatitis—Melphalan—hematologic cancer	0.000288	0.000718	CcSEcCtD
Trimetrexate—Pruritus—Bleomycin—hematologic cancer	0.000287	0.000716	CcSEcCtD
Trimetrexate—Convulsion—Prednisolone—hematologic cancer	0.000287	0.000716	CcSEcCtD
Trimetrexate—Asthenia—Vinorelbine—hematologic cancer	0.000286	0.000715	CcSEcCtD
Trimetrexate—Feeling abnormal—Ifosfamide—hematologic cancer	0.000286	0.000713	CcSEcCtD
Trimetrexate—Nausea—Vinblastine—hematologic cancer	0.000285	0.000712	CcSEcCtD
Trimetrexate—DHFR—Metabolism—HDC—hematologic cancer	0.000285	0.00173	CbGpPWpGaD
Trimetrexate—Fatigue—Irinotecan—hematologic cancer	0.000284	0.000708	CcSEcCtD
Trimetrexate—Fatigue—Mitoxantrone—hematologic cancer	0.000284	0.000708	CcSEcCtD
Trimetrexate—Vomiting—Lenalidomide—hematologic cancer	0.000282	0.000705	CcSEcCtD
Trimetrexate—Pruritus—Vinorelbine—hematologic cancer	0.000282	0.000705	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Epirubicin—hematologic cancer	0.000281	0.000702	CcSEcCtD
Trimetrexate—Rash—Lenalidomide—hematologic cancer	0.00028	0.000699	CcSEcCtD
Trimetrexate—Body temperature increased—Carmustine—hematologic cancer	0.00028	0.000699	CcSEcCtD
Trimetrexate—Dermatitis—Lenalidomide—hematologic cancer	0.00028	0.000699	CcSEcCtD
Trimetrexate—Vomiting—Hydroxyurea—hematologic cancer	0.000279	0.000695	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CCND1—hematologic cancer	0.000279	0.00169	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MLH1—hematologic cancer	0.000278	0.00169	CbGpPWpGaD
Trimetrexate—Body temperature increased—Alitretinoin—hematologic cancer	0.000277	0.000692	CcSEcCtD
Trimetrexate—Fatigue—Gemcitabine—hematologic cancer	0.000276	0.00069	CcSEcCtD
Trimetrexate—Rash—Hydroxyurea—hematologic cancer	0.000276	0.000689	CcSEcCtD
Trimetrexate—Confusional state—Etoposide—hematologic cancer	0.000276	0.000689	CcSEcCtD
Trimetrexate—Dermatitis—Hydroxyurea—hematologic cancer	0.000276	0.000689	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Epirubicin—hematologic cancer	0.000275	0.000688	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDK6—hematologic cancer	0.000274	0.00167	CbGpPWpGaD
Trimetrexate—Body temperature increased—Ifosfamide—hematologic cancer	0.000274	0.000684	CcSEcCtD
Trimetrexate—Asthenia—Thiotepa—hematologic cancer	0.000274	0.000683	CcSEcCtD
Trimetrexate—Nausea—Melphalan—hematologic cancer	0.000271	0.000677	CcSEcCtD
Trimetrexate—Feeling abnormal—Irinotecan—hematologic cancer	0.000271	0.000677	CcSEcCtD
Trimetrexate—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000271	0.000677	CcSEcCtD
Trimetrexate—Blood creatinine increased—Doxorubicin—hematologic cancer	0.000271	0.000676	CcSEcCtD
Trimetrexate—Neutropenia—Methotrexate—hematologic cancer	0.00027	0.000673	CcSEcCtD
Trimetrexate—Pruritus—Thiotepa—hematologic cancer	0.00027	0.000673	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDKN1A—hematologic cancer	0.000269	0.00164	CbGpPWpGaD
Trimetrexate—Thrombocytopenia—Etoposide—hematologic cancer	0.000268	0.000669	CcSEcCtD
Trimetrexate—Body temperature increased—Vincristine—hematologic cancer	0.000267	0.000667	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—SMC1A—hematologic cancer	0.000266	0.00162	CbGpPWpGaD
Trimetrexate—DHFR—G1/S Transition—MYC—hematologic cancer	0.000265	0.00161	CbGpPWpGaD
Trimetrexate—Asthenia—Thalidomide—hematologic cancer	0.000265	0.00066	CcSEcCtD
Trimetrexate—Feeling abnormal—Gemcitabine—hematologic cancer	0.000264	0.00066	CcSEcCtD
Trimetrexate—Nausea—Lenalidomide—hematologic cancer	0.000264	0.000659	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—TOP2A—hematologic cancer	0.000264	0.00161	CbGpPWpGaD
Trimetrexate—Convulsion—Triamcinolone—hematologic cancer	0.000264	0.000658	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—H3F3A—hematologic cancer	0.000261	0.00159	CbGpPWpGaD
Trimetrexate—Pruritus—Thalidomide—hematologic cancer	0.000261	0.000651	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	0.000261	0.00159	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CDA—hematologic cancer	0.00026	0.00158	CbGpPWpGaD
Trimetrexate—Body temperature increased—Mitoxantrone—hematologic cancer	0.00026	0.00065	CcSEcCtD
Trimetrexate—Body temperature increased—Irinotecan—hematologic cancer	0.00026	0.00065	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Doxorubicin—hematologic cancer	0.00026	0.00065	CcSEcCtD
Trimetrexate—Nausea—Hydroxyurea—hematologic cancer	0.00026	0.000649	CcSEcCtD
Trimetrexate—Vomiting—Bortezomib—hematologic cancer	0.00026	0.000649	CcSEcCtD
Trimetrexate—Vomiting—Bleomycin—hematologic cancer	0.000258	0.000644	CcSEcCtD
Trimetrexate—Rash—Bortezomib—hematologic cancer	0.000258	0.000643	CcSEcCtD
Trimetrexate—Dermatitis—Bortezomib—hematologic cancer	0.000258	0.000643	CcSEcCtD
Trimetrexate—Rash—Bleomycin—hematologic cancer	0.000256	0.000638	CcSEcCtD
Trimetrexate—Dermatitis—Bleomycin—hematologic cancer	0.000256	0.000638	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Doxorubicin—hematologic cancer	0.000255	0.000636	CcSEcCtD
Trimetrexate—Asthenia—Carmustine—hematologic cancer	0.000254	0.000634	CcSEcCtD
Trimetrexate—Vomiting—Vinorelbine—hematologic cancer	0.000254	0.000634	CcSEcCtD
Trimetrexate—Body temperature increased—Gemcitabine—hematologic cancer	0.000254	0.000633	CcSEcCtD
Trimetrexate—Neutropenia—Epirubicin—hematologic cancer	0.000252	0.00063	CcSEcCtD
Trimetrexate—Asthenia—Alitretinoin—hematologic cancer	0.000252	0.000628	CcSEcCtD
Trimetrexate—Rash—Vinorelbine—hematologic cancer	0.000252	0.000628	CcSEcCtD
Trimetrexate—Dermatitis—Vinorelbine—hematologic cancer	0.000251	0.000628	CcSEcCtD
Trimetrexate—DHFR—Metabolism—PC—hematologic cancer	0.000251	0.00153	CbGpPWpGaD
Trimetrexate—Asthenia—Ifosfamide—hematologic cancer	0.000249	0.000621	CcSEcCtD
Trimetrexate—Pruritus—Alitretinoin—hematologic cancer	0.000248	0.00062	CcSEcCtD
Trimetrexate—Feeling abnormal—Cisplatin—hematologic cancer	0.000246	0.000615	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	0.000246	0.0015	CbGpPWpGaD
Trimetrexate—Pruritus—Ifosfamide—hematologic cancer	0.000245	0.000612	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—CDK6—hematologic cancer	0.000245	0.00149	CbGpPWpGaD
Trimetrexate—Nausea—Bortezomib—hematologic cancer	0.000243	0.000606	CcSEcCtD
Trimetrexate—Asthenia—Vincristine—hematologic cancer	0.000243	0.000605	CcSEcCtD
Trimetrexate—Vomiting—Thiotepa—hematologic cancer	0.000242	0.000605	CcSEcCtD
Trimetrexate—DHFR—Metabolism—GBA—hematologic cancer	0.000242	0.00147	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SLC35B2—hematologic cancer	0.000242	0.00147	CbGpPWpGaD
Trimetrexate—Nausea—Bleomycin—hematologic cancer	0.000241	0.000601	CcSEcCtD
Trimetrexate—Rash—Thiotepa—hematologic cancer	0.00024	0.0006	CcSEcCtD
Trimetrexate—Dermatitis—Thiotepa—hematologic cancer	0.00024	0.000599	CcSEcCtD
Trimetrexate—Convulsion—Betamethasone—hematologic cancer	0.000239	0.000597	CcSEcCtD
Trimetrexate—Convulsion—Dexamethasone—hematologic cancer	0.000239	0.000597	CcSEcCtD
Trimetrexate—Nausea—Vinorelbine—hematologic cancer	0.000237	0.000592	CcSEcCtD
Trimetrexate—Body temperature increased—Cisplatin—hematologic cancer	0.000236	0.00059	CcSEcCtD
Trimetrexate—Asthenia—Mitoxantrone—hematologic cancer	0.000236	0.00059	CcSEcCtD
Trimetrexate—Asthenia—Irinotecan—hematologic cancer	0.000236	0.00059	CcSEcCtD
Trimetrexate—Fatigue—Etoposide—hematologic cancer	0.000236	0.000589	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CCND2—hematologic cancer	0.000236	0.00144	CbGpPWpGaD
Trimetrexate—Vomiting—Thalidomide—hematologic cancer	0.000234	0.000585	CcSEcCtD
Trimetrexate—Neutropenia—Doxorubicin—hematologic cancer	0.000234	0.000583	CcSEcCtD
Trimetrexate—Rash—Thalidomide—hematologic cancer	0.000232	0.00058	CcSEcCtD
Trimetrexate—Dermatitis—Thalidomide—hematologic cancer	0.000232	0.00058	CcSEcCtD
Trimetrexate—DHFR—Disease—AGRN—hematologic cancer	0.000231	0.00141	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPLP1—hematologic cancer	0.000231	0.00141	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SNCA—hematologic cancer	0.000231	0.00141	CbGpPWpGaD
Trimetrexate—Asthenia—Gemcitabine—hematologic cancer	0.00023	0.000574	CcSEcCtD
Trimetrexate—Pruritus—Gemcitabine—hematologic cancer	0.000227	0.000566	CcSEcCtD
Trimetrexate—Nausea—Thiotepa—hematologic cancer	0.000226	0.000565	CcSEcCtD
Trimetrexate—Feeling abnormal—Etoposide—hematologic cancer	0.000226	0.000563	CcSEcCtD
Trimetrexate—Vomiting—Carmustine—hematologic cancer	0.000225	0.000562	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—MYC—hematologic cancer	0.000223	0.00136	CbGpPWpGaD
Trimetrexate—Rash—Carmustine—hematologic cancer	0.000223	0.000557	CcSEcCtD
Trimetrexate—Dermatitis—Carmustine—hematologic cancer	0.000223	0.000557	CcSEcCtD
Trimetrexate—Vomiting—Alitretinoin—hematologic cancer	0.000223	0.000557	CcSEcCtD
Trimetrexate—DHFR—Disease—LEF1—hematologic cancer	0.000223	0.00136	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Prednisolone—hematologic cancer	0.000223	0.000556	CcSEcCtD
Trimetrexate—Anaemia—Prednisone—hematologic cancer	0.000222	0.000555	CcSEcCtD
Trimetrexate—DHFR—Metabolism—MTAP—hematologic cancer	0.000221	0.00135	CbGpPWpGaD
Trimetrexate—Rash—Alitretinoin—hematologic cancer	0.000221	0.000552	CcSEcCtD
Trimetrexate—Dermatitis—Alitretinoin—hematologic cancer	0.000221	0.000552	CcSEcCtD
Trimetrexate—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000221	0.000551	CcSEcCtD
Trimetrexate—Thrombocytopenia—Betamethasone—hematologic cancer	0.000221	0.000551	CcSEcCtD
Trimetrexate—Vomiting—Ifosfamide—hematologic cancer	0.00022	0.00055	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—HSP90AA1—hematologic cancer	0.00022	0.00134	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HMMR—hematologic cancer	0.000219	0.00133	CbGpPWpGaD
Trimetrexate—Nausea—Thalidomide—hematologic cancer	0.000219	0.000547	CcSEcCtD
Trimetrexate—Rash—Ifosfamide—hematologic cancer	0.000219	0.000546	CcSEcCtD
Trimetrexate—Dermatitis—Ifosfamide—hematologic cancer	0.000218	0.000545	CcSEcCtD
Trimetrexate—Body temperature increased—Etoposide—hematologic cancer	0.000216	0.00054	CcSEcCtD
Trimetrexate—Vomiting—Vincristine—hematologic cancer	0.000215	0.000536	CcSEcCtD
Trimetrexate—Asthenia—Cisplatin—hematologic cancer	0.000214	0.000535	CcSEcCtD
Trimetrexate—Fatigue—Triamcinolone—hematologic cancer	0.000214	0.000535	CcSEcCtD
Trimetrexate—Rash—Vincristine—hematologic cancer	0.000213	0.000532	CcSEcCtD
Trimetrexate—Dermatitis—Vincristine—hematologic cancer	0.000213	0.000532	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	0.000211	0.00129	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CCND2—hematologic cancer	0.000211	0.00128	CbGpPWpGaD
Trimetrexate—Nausea—Carmustine—hematologic cancer	0.00021	0.000525	CcSEcCtD
Trimetrexate—Vomiting—Mitoxantrone—hematologic cancer	0.000209	0.000522	CcSEcCtD
Trimetrexate—Vomiting—Irinotecan—hematologic cancer	0.000209	0.000522	CcSEcCtD
Trimetrexate—Nausea—Alitretinoin—hematologic cancer	0.000208	0.00052	CcSEcCtD
Trimetrexate—Convulsion—Prednisone—hematologic cancer	0.000208	0.00052	CcSEcCtD
Trimetrexate—Rash—Irinotecan—hematologic cancer	0.000208	0.000518	CcSEcCtD
Trimetrexate—Rash—Mitoxantrone—hematologic cancer	0.000208	0.000518	CcSEcCtD
Trimetrexate—Dermatitis—Irinotecan—hematologic cancer	0.000207	0.000518	CcSEcCtD
Trimetrexate—Dermatitis—Mitoxantrone—hematologic cancer	0.000207	0.000518	CcSEcCtD
Trimetrexate—Nausea—Ifosfamide—hematologic cancer	0.000206	0.000514	CcSEcCtD
Trimetrexate—DHFR—Disease—ELL—hematologic cancer	0.000206	0.00125	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Triamcinolone—hematologic cancer	0.000205	0.000511	CcSEcCtD
Trimetrexate—Vomiting—Gemcitabine—hematologic cancer	0.000204	0.000509	CcSEcCtD
Trimetrexate—Rash—Gemcitabine—hematologic cancer	0.000202	0.000505	CcSEcCtD
Trimetrexate—Dermatitis—Gemcitabine—hematologic cancer	0.000202	0.000504	CcSEcCtD
Trimetrexate—Nausea—Vincristine—hematologic cancer	0.000201	0.000501	CcSEcCtD
Trimetrexate—DHFR—Disease—ACP5—hematologic cancer	0.0002	0.00122	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NCOR2—hematologic cancer	0.000198	0.0012	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—FHL2—hematologic cancer	0.000197	0.0012	CbGpPWpGaD
Trimetrexate—Asthenia—Etoposide—hematologic cancer	0.000196	0.00049	CcSEcCtD
Trimetrexate—Body temperature increased—Triamcinolone—hematologic cancer	0.000196	0.00049	CcSEcCtD
Trimetrexate—Nausea—Mitoxantrone—hematologic cancer	0.000196	0.000488	CcSEcCtD
Trimetrexate—Nausea—Irinotecan—hematologic cancer	0.000196	0.000488	CcSEcCtD
Trimetrexate—Fatigue—Betamethasone—hematologic cancer	0.000194	0.000485	CcSEcCtD
Trimetrexate—Fatigue—Dexamethasone—hematologic cancer	0.000194	0.000485	CcSEcCtD
Trimetrexate—Pruritus—Etoposide—hematologic cancer	0.000194	0.000484	CcSEcCtD
Trimetrexate—DHFR—Metabolism—AGRN—hematologic cancer	0.000194	0.00118	CbGpPWpGaD
Trimetrexate—Nausea—Gemcitabine—hematologic cancer	0.00019	0.000475	CcSEcCtD
Trimetrexate—Vomiting—Cisplatin—hematologic cancer	0.00019	0.000474	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—CDKN2B—hematologic cancer	0.000189	0.00115	CbGpPWpGaD
Trimetrexate—Rash—Cisplatin—hematologic cancer	0.000188	0.00047	CcSEcCtD
Trimetrexate—DHFR—Disease—IDH1—hematologic cancer	0.000188	0.00115	CbGpPWpGaD
Trimetrexate—Dermatitis—Cisplatin—hematologic cancer	0.000188	0.00047	CcSEcCtD
Trimetrexate—DHFR—Disease—GSTO1—hematologic cancer	0.000186	0.00113	CbGpPWpGaD
Trimetrexate—Anaemia—Methotrexate—hematologic cancer	0.000186	0.000464	CcSEcCtD
Trimetrexate—Feeling abnormal—Dexamethasone—hematologic cancer	0.000186	0.000464	CcSEcCtD
Trimetrexate—Feeling abnormal—Betamethasone—hematologic cancer	0.000186	0.000464	CcSEcCtD
Trimetrexate—DHFR—Metabolism—IDH2—hematologic cancer	0.000183	0.00112	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HMMR—hematologic cancer	0.000183	0.00112	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—BIRC5—hematologic cancer	0.000182	0.00111	CbGpPWpGaD
Trimetrexate—DHFR—Disease—AGO2—hematologic cancer	0.000182	0.00111	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HDAC9—hematologic cancer	0.00018	0.0011	CbGpPWpGaD
Trimetrexate—DHFR—Disease—H3F3B—hematologic cancer	0.000179	0.00109	CbGpPWpGaD
Trimetrexate—Asthenia—Triamcinolone—hematologic cancer	0.000178	0.000445	CcSEcCtD
Trimetrexate—Body temperature increased—Dexamethasone—hematologic cancer	0.000178	0.000445	CcSEcCtD
Trimetrexate—Body temperature increased—Betamethasone—hematologic cancer	0.000178	0.000445	CcSEcCtD
Trimetrexate—Nausea—Cisplatin—hematologic cancer	0.000178	0.000443	CcSEcCtD
Trimetrexate—Pruritus—Triamcinolone—hematologic cancer	0.000176	0.000439	CcSEcCtD
Trimetrexate—Convulsion—Methotrexate—hematologic cancer	0.000174	0.000435	CcSEcCtD
Trimetrexate—Vomiting—Etoposide—hematologic cancer	0.000174	0.000435	CcSEcCtD
Trimetrexate—Anaemia—Epirubicin—hematologic cancer	0.000174	0.000434	CcSEcCtD
Trimetrexate—Rash—Etoposide—hematologic cancer	0.000173	0.000431	CcSEcCtD
Trimetrexate—Dermatitis—Etoposide—hematologic cancer	0.000173	0.000431	CcSEcCtD
Trimetrexate—DHFR—Metabolism—ARNTL—hematologic cancer	0.000172	0.00105	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NPM1—hematologic cancer	0.000172	0.00105	CbGpPWpGaD
Trimetrexate—Rash—Prednisolone—hematologic cancer	0.00017	0.000425	CcSEcCtD
Trimetrexate—Dermatitis—Prednisolone—hematologic cancer	0.00017	0.000425	CcSEcCtD
Trimetrexate—Fatigue—Prednisone—hematologic cancer	0.000169	0.000422	CcSEcCtD
Trimetrexate—DHFR—Metabolism—CA9—hematologic cancer	0.000168	0.00102	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ACP5—hematologic cancer	0.000168	0.00102	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDK2—hematologic cancer	0.000167	0.00102	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NCOR2—hematologic cancer	0.000166	0.00101	CbGpPWpGaD
Trimetrexate—Confusional state—Methotrexate—hematologic cancer	0.000165	0.000413	CcSEcCtD
Trimetrexate—DHFR—Disease—FGF19—hematologic cancer	0.000165	0.001	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPS14—hematologic cancer	0.000163	0.000994	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—BIRC5—hematologic cancer	0.000163	0.000993	CbGpPWpGaD
Trimetrexate—Convulsion—Epirubicin—hematologic cancer	0.000163	0.000407	CcSEcCtD
Trimetrexate—Nausea—Etoposide—hematologic cancer	0.000163	0.000406	CcSEcCtD
Trimetrexate—DHFR—Disease—DKK1—hematologic cancer	0.000162	0.000986	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Prednisone—hematologic cancer	0.000162	0.000404	CcSEcCtD
Trimetrexate—Asthenia—Dexamethasone—hematologic cancer	0.000162	0.000404	CcSEcCtD
Trimetrexate—Asthenia—Betamethasone—hematologic cancer	0.000162	0.000404	CcSEcCtD
Trimetrexate—Anaemia—Doxorubicin—hematologic cancer	0.000161	0.000401	CcSEcCtD
Trimetrexate—DHFR—Disease—STAT5B—hematologic cancer	0.000161	0.000978	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NUP98—hematologic cancer	0.000161	0.000978	CbGpPWpGaD
Trimetrexate—Thrombocytopenia—Methotrexate—hematologic cancer	0.000161	0.000401	CcSEcCtD
Trimetrexate—Nausea—Prednisolone—hematologic cancer	0.00016	0.0004	CcSEcCtD
Trimetrexate—Pruritus—Dexamethasone—hematologic cancer	0.000159	0.000398	CcSEcCtD
Trimetrexate—Pruritus—Betamethasone—hematologic cancer	0.000159	0.000398	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDK4—hematologic cancer	0.000158	0.000963	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—TERT—hematologic cancer	0.000158	0.000962	CbGpPWpGaD
Trimetrexate—Vomiting—Triamcinolone—hematologic cancer	0.000158	0.000394	CcSEcCtD
Trimetrexate—DHFR—Metabolism—IDH1—hematologic cancer	0.000158	0.00096	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CST3—hematologic cancer	0.000157	0.000957	CbGpPWpGaD
Trimetrexate—Rash—Triamcinolone—hematologic cancer	0.000157	0.000391	CcSEcCtD
Trimetrexate—Dermatitis—Triamcinolone—hematologic cancer	0.000156	0.000391	CcSEcCtD
Trimetrexate—DHFR—Disease—ADCY7—hematologic cancer	0.000156	0.00095	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTO1—hematologic cancer	0.000156	0.000949	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—TXN—hematologic cancer	0.000156	0.000949	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCC3—hematologic cancer	0.000156	0.000949	CbGpPWpGaD
Trimetrexate—Body temperature increased—Prednisone—hematologic cancer	0.000155	0.000387	CcSEcCtD
Trimetrexate—DHFR—Disease—NUP214—hematologic cancer	0.000155	0.000943	CbGpPWpGaD
Trimetrexate—Confusional state—Epirubicin—hematologic cancer	0.000155	0.000386	CcSEcCtD
Trimetrexate—DHFR—Metabolism—SPHK1—hematologic cancer	0.000153	0.000929	CbGpPWpGaD
Trimetrexate—DHFR—Disease—XIAP—hematologic cancer	0.000152	0.000924	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MTR—hematologic cancer	0.000152	0.000924	CbGpPWpGaD
Trimetrexate—Convulsion—Doxorubicin—hematologic cancer	0.000151	0.000376	CcSEcCtD
Trimetrexate—Thrombocytopenia—Epirubicin—hematologic cancer	0.00015	0.000375	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—CDK2—hematologic cancer	0.00015	0.000911	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ENO2—hematologic cancer	0.000149	0.000906	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SMARCA4—hematologic cancer	0.000148	0.0009	CbGpPWpGaD
Trimetrexate—Nausea—Triamcinolone—hematologic cancer	0.000148	0.000368	CcSEcCtD
Trimetrexate—DHFR—Metabolism—UGT1A1—hematologic cancer	0.000147	0.000892	CbGpPWpGaD
Trimetrexate—Vomiting—Betamethasone—hematologic cancer	0.000143	0.000358	CcSEcCtD
Trimetrexate—Vomiting—Dexamethasone—hematologic cancer	0.000143	0.000358	CcSEcCtD
Trimetrexate—Confusional state—Doxorubicin—hematologic cancer	0.000143	0.000357	CcSEcCtD
Trimetrexate—DHFR—Metabolism—SLC22A1—hematologic cancer	0.000143	0.000868	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CRABP1—hematologic cancer	0.000143	0.000868	CbGpPWpGaD
Trimetrexate—Rash—Betamethasone—hematologic cancer	0.000142	0.000355	CcSEcCtD
Trimetrexate—Rash—Dexamethasone—hematologic cancer	0.000142	0.000355	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—ATM—hematologic cancer	0.000142	0.000864	CbGpPWpGaD
Trimetrexate—Dermatitis—Betamethasone—hematologic cancer	0.000142	0.000354	CcSEcCtD
Trimetrexate—Dermatitis—Dexamethasone—hematologic cancer	0.000142	0.000354	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—CDK4—hematologic cancer	0.000141	0.000861	CbGpPWpGaD
Trimetrexate—Fatigue—Methotrexate—hematologic cancer	0.000141	0.000353	CcSEcCtD
Trimetrexate—DHFR—Disease—SDC1—hematologic cancer	0.000141	0.000859	CbGpPWpGaD
Trimetrexate—Asthenia—Prednisone—hematologic cancer	0.000141	0.000351	CcSEcCtD
Trimetrexate—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000139	0.000347	CcSEcCtD
Trimetrexate—DHFR—Metabolism—ALOX5—hematologic cancer	0.000139	0.000846	CbGpPWpGaD
Trimetrexate—Pruritus—Prednisone—hematologic cancer	0.000139	0.000347	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—RB1—hematologic cancer	0.000138	0.000837	CbGpPWpGaD
Trimetrexate—DHFR—Disease—LCK—hematologic cancer	0.000137	0.000832	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Methotrexate—hematologic cancer	0.000135	0.000337	CcSEcCtD
Trimetrexate—DHFR—Metabolism—NUP98—hematologic cancer	0.000135	0.000819	CbGpPWpGaD
Trimetrexate—DHFR—Disease—H3F3A—hematologic cancer	0.000134	0.000815	CbGpPWpGaD
Trimetrexate—Nausea—Betamethasone—hematologic cancer	0.000134	0.000334	CcSEcCtD
Trimetrexate—Nausea—Dexamethasone—hematologic cancer	0.000134	0.000334	CcSEcCtD
Trimetrexate—Fatigue—Epirubicin—hematologic cancer	0.000132	0.00033	CcSEcCtD
Trimetrexate—DHFR—Metabolism—ADCY7—hematologic cancer	0.000131	0.000795	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NCOA3—hematologic cancer	0.000131	0.000795	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PRKCZ—hematologic cancer	0.00013	0.000793	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NUP214—hematologic cancer	0.00013	0.00079	CbGpPWpGaD
Trimetrexate—Body temperature increased—Methotrexate—hematologic cancer	0.00013	0.000324	CcSEcCtD
Trimetrexate—DHFR—Disease—CALR—hematologic cancer	0.000128	0.000779	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MTR—hematologic cancer	0.000127	0.000774	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCG2—hematologic cancer	0.000127	0.000774	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Epirubicin—hematologic cancer	0.000126	0.000316	CcSEcCtD
Trimetrexate—DHFR—Disease—PARP1—hematologic cancer	0.000126	0.000766	CbGpPWpGaD
Trimetrexate—Vomiting—Prednisone—hematologic cancer	0.000125	0.000311	CcSEcCtD
Trimetrexate—DHFR—Metabolism—ENO2—hematologic cancer	0.000125	0.000759	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FBXW7—hematologic cancer	0.000124	0.000753	CbGpPWpGaD
Trimetrexate—Rash—Prednisone—hematologic cancer	0.000124	0.000309	CcSEcCtD
Trimetrexate—Dermatitis—Prednisone—hematologic cancer	0.000124	0.000309	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—RB1—hematologic cancer	0.000123	0.000748	CbGpPWpGaD
Trimetrexate—Fatigue—Doxorubicin—hematologic cancer	0.000122	0.000306	CcSEcCtD
Trimetrexate—DHFR—Disease—CXCR4—hematologic cancer	0.000121	0.000739	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HDAC2—hematologic cancer	0.000121	0.000739	CbGpPWpGaD
Trimetrexate—Body temperature increased—Epirubicin—hematologic cancer	0.000121	0.000303	CcSEcCtD
Trimetrexate—DHFR—Metabolism—GSTT1—hematologic cancer	0.000121	0.000736	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	0.000121	0.000736	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CD44—hematologic cancer	0.00012	0.00073	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CBL—hematologic cancer	0.000118	0.00072	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SDC1—hematologic cancer	0.000118	0.000719	CbGpPWpGaD
Trimetrexate—Asthenia—Methotrexate—hematologic cancer	0.000118	0.000294	CcSEcCtD
Trimetrexate—Feeling abnormal—Doxorubicin—hematologic cancer	0.000117	0.000292	CcSEcCtD
Trimetrexate—Nausea—Prednisone—hematologic cancer	0.000117	0.000291	CcSEcCtD
Trimetrexate—Pruritus—Methotrexate—hematologic cancer	0.000116	0.00029	CcSEcCtD
Trimetrexate—DHFR—Disease—HSP90AA1—hematologic cancer	0.000113	0.000687	CbGpPWpGaD
Trimetrexate—Body temperature increased—Doxorubicin—hematologic cancer	0.000112	0.00028	CcSEcCtD
Trimetrexate—Asthenia—Epirubicin—hematologic cancer	0.00011	0.000275	CcSEcCtD
Trimetrexate—DHFR—Disease—STAT1—hematologic cancer	0.000109	0.000662	CbGpPWpGaD
Trimetrexate—Pruritus—Epirubicin—hematologic cancer	0.000109	0.000271	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—CDKN2A—hematologic cancer	0.000108	0.000658	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	0.000107	0.000652	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MDM2—hematologic cancer	0.000105	0.000638	CbGpPWpGaD
Trimetrexate—Vomiting—Methotrexate—hematologic cancer	0.000104	0.00026	CcSEcCtD
Trimetrexate—Rash—Methotrexate—hematologic cancer	0.000103	0.000258	CcSEcCtD
Trimetrexate—Dermatitis—Methotrexate—hematologic cancer	0.000103	0.000258	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CCND1—hematologic cancer	0.000102	0.000622	CbGpPWpGaD
Trimetrexate—Asthenia—Doxorubicin—hematologic cancer	0.000102	0.000254	CcSEcCtD
Trimetrexate—DHFR—Disease—GRB2—hematologic cancer	0.000102	0.000619	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PDGFA—hematologic cancer	0.000102	0.000618	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NQO1—hematologic cancer	0.000101	0.000612	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CD44—hematologic cancer	0.000101	0.000612	CbGpPWpGaD
Trimetrexate—Pruritus—Doxorubicin—hematologic cancer	0.0001	0.000251	CcSEcCtD
Trimetrexate—DHFR—Disease—KITLG—hematologic cancer	0.0001	0.000609	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	9.88e-05	0.000601	CbGpPWpGaD
Trimetrexate—DHFR—Disease—STAT5A—hematologic cancer	9.78e-05	0.000595	CbGpPWpGaD
Trimetrexate—Vomiting—Epirubicin—hematologic cancer	9.76e-05	0.000244	CcSEcCtD
Trimetrexate—Nausea—Methotrexate—hematologic cancer	9.74e-05	0.000243	CcSEcCtD
Trimetrexate—DHFR—Disease—CDKN2B—hematologic cancer	9.7e-05	0.00059	CbGpPWpGaD
Trimetrexate—Rash—Epirubicin—hematologic cancer	9.68e-05	0.000242	CcSEcCtD
Trimetrexate—Dermatitis—Epirubicin—hematologic cancer	9.67e-05	0.000241	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—CDKN1B—hematologic cancer	9.57e-05	0.000583	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYCS—hematologic cancer	9.51e-05	0.000579	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HSP90AA1—hematologic cancer	9.45e-05	0.000575	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—EP300—hematologic cancer	9.4e-05	0.000572	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CD86—hematologic cancer	9.38e-05	0.000571	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HES1—hematologic cancer	9.25e-05	0.000563	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NCOR1—hematologic cancer	9.2e-05	0.00056	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CCND1—hematologic cancer	9.13e-05	0.000556	CbGpPWpGaD
Trimetrexate—Nausea—Epirubicin—hematologic cancer	9.12e-05	0.000228	CcSEcCtD
Trimetrexate—DHFR—Disease—FGF1—hematologic cancer	9.1e-05	0.000554	CbGpPWpGaD
Trimetrexate—Vomiting—Doxorubicin—hematologic cancer	9.03e-05	0.000225	CcSEcCtD
Trimetrexate—DHFR—Disease—FOXO1—hematologic cancer	8.96e-05	0.000546	CbGpPWpGaD
Trimetrexate—Rash—Doxorubicin—hematologic cancer	8.96e-05	0.000224	CcSEcCtD
Trimetrexate—DHFR—Disease—PDGFRB—hematologic cancer	8.95e-05	0.000545	CbGpPWpGaD
Trimetrexate—Dermatitis—Doxorubicin—hematologic cancer	8.95e-05	0.000223	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—CDKN1A—hematologic cancer	8.84e-05	0.000538	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PDGFRA—hematologic cancer	8.81e-05	0.000536	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PRKCG—hematologic cancer	8.78e-05	0.000534	CbGpPWpGaD
Trimetrexate—DHFR—Disease—JAK1—hematologic cancer	8.78e-05	0.000534	CbGpPWpGaD
Trimetrexate—Nausea—Doxorubicin—hematologic cancer	8.44e-05	0.000211	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MAPK3—hematologic cancer	8.42e-05	0.000513	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—EP300—hematologic cancer	8.41e-05	0.000512	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTP1—hematologic cancer	8.38e-05	0.00051	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MYC—hematologic cancer	8.19e-05	0.000499	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MTHFR—hematologic cancer	8.13e-05	0.000495	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TERT—hematologic cancer	8.11e-05	0.000493	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HLA-A—hematologic cancer	8.11e-05	0.000493	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCB1—hematologic cancer	7.94e-05	0.000483	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PDGFB—hematologic cancer	7.91e-05	0.000482	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TSC2—hematologic cancer	7.73e-05	0.000471	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTM1—hematologic cancer	7.7e-05	0.000469	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NCOR1—hematologic cancer	7.7e-05	0.000469	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MAPK3—hematologic cancer	7.53e-05	0.000458	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGFR3—hematologic cancer	7.44e-05	0.000453	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MYC—hematologic cancer	7.33e-05	0.000446	CbGpPWpGaD
Trimetrexate—DHFR—Disease—BAD—hematologic cancer	7.05e-05	0.000429	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NOTCH1—hematologic cancer	6.98e-05	0.000425	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CD80—hematologic cancer	6.84e-05	0.000416	CbGpPWpGaD
Trimetrexate—DHFR—Disease—KIT—hematologic cancer	6.83e-05	0.000416	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MTHFR—hematologic cancer	6.81e-05	0.000414	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PTPN11—hematologic cancer	6.71e-05	0.000408	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CREB1—hematologic cancer	6.5e-05	0.000396	CbGpPWpGaD
Trimetrexate—DHFR—Disease—BRAF—hematologic cancer	6.42e-05	0.000391	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IL6R—hematologic cancer	6.34e-05	0.000386	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CREBBP—hematologic cancer	6.33e-05	0.000385	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MAP2K1—hematologic cancer	6.04e-05	0.000368	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—TP53—hematologic cancer	6.02e-05	0.000366	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PIK3CD—hematologic cancer	6e-05	0.000365	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGF2—hematologic cancer	5.75e-05	0.00035	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CG—hematologic cancer	5.72e-05	0.000348	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PIK3R1—hematologic cancer	5.67e-05	0.000345	CbGpPWpGaD
Trimetrexate—DHFR—Disease—JAK2—hematologic cancer	5.51e-05	0.000335	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MDM2—hematologic cancer	5.38e-05	0.000327	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CREBBP—hematologic cancer	5.3e-05	0.000323	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MTOR—hematologic cancer	5.23e-05	0.000318	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PIK3CB—hematologic cancer	5.23e-05	0.000318	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CD4—hematologic cancer	5.22e-05	0.000318	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CD—hematologic cancer	5.03e-05	0.000306	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALB—hematologic cancer	4.96e-05	0.000302	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CDKN1B—hematologic cancer	4.91e-05	0.000299	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3R1—hematologic cancer	4.75e-05	0.000289	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CDKN1A—hematologic cancer	4.53e-05	0.000276	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PTEN—hematologic cancer	4.52e-05	0.000275	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CB—hematologic cancer	4.38e-05	0.000267	CbGpPWpGaD
Trimetrexate—DHFR—Disease—EP300—hematologic cancer	4.31e-05	0.000262	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SRC—hematologic cancer	4.19e-05	0.000255	CbGpPWpGaD
Trimetrexate—DHFR—Disease—STAT3—hematologic cancer	4.04e-05	0.000246	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NRAS—hematologic cancer	4.03e-05	0.000246	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MAPK3—hematologic cancer	3.86e-05	0.000235	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PTEN—hematologic cancer	3.79e-05	0.00023	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MYC—hematologic cancer	3.76e-05	0.000229	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TGFB1—hematologic cancer	3.75e-05	0.000228	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—EP300—hematologic cancer	3.61e-05	0.00022	CbGpPWpGaD
Trimetrexate—DHFR—Disease—KRAS—hematologic cancer	3.47e-05	0.000211	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PIK3CA—hematologic cancer	3.19e-05	0.000194	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HRAS—hematologic cancer	2.95e-05	0.00018	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IL6—hematologic cancer	2.83e-05	0.000172	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CA—hematologic cancer	2.67e-05	0.000163	CbGpPWpGaD
Trimetrexate—DHFR—Disease—AKT1—hematologic cancer	2.61e-05	0.000159	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—AKT1—hematologic cancer	2.18e-05	0.000133	CbGpPWpGaD
